Professional Overview
Brian Harraka is a seasoned financial executive currently serving as the Chief Financial Officer at Eisai US, located in Wayne, New Jersey, United States. His key expertise areas include financial planning, accounting, and assurance, with a strong industry focus on pharmaceuticals and healthcare.
Experience Summary
Current Role
As the Chief Financial Officer at Eisai US, Brian oversees all financial aspects of the organization, including financial planning, reporting, and strategy development. His key responsibilities encompass leading the financial team, driving business growth, and ensuring compliance with regulatory requirements. Although specific achievements in his current role are not available, his leadership is expected to significantly impact the company's financial performance and strategic direction.
Career Progression
Brian's career progression is marked by notable previous roles that have contributed to his growth and expertise. He previously served as Executive Director - Accounting at Novartis from 2013 to 2019, where he led accounting operations and ensured financial compliance. Before Novartis, Brian held the position of Manager, Financial Planning & Reporting at Reckitt Benckiser from 2003 to 2006, focusing on financial planning and analysis. His early career began at KPMG Peat Marwick as a Senior Associate, Assurance from 2000 to 2002, laying the foundation for his future roles in finance and accounting.
Areas of Expertise
Brian's areas of expertise include:
- Industry-specific skills in pharmaceutical finance and accounting
- Technical competencies in financial planning, reporting, and assurance
- Leadership and management capabilities, with a proven track record of leading financial teams and driving business growth
Professional Impact
Although specific projects or initiatives are not detailed, Brian's contributions to the pharmaceutical industry are significant. His experience and leadership have likely impacted the financial performance and strategic direction of his previous and current organizations.
Conclusion
Brian Harraka's professional trajectory is marked by significant growth and leadership in the financial sector of the pharmaceutical industry. Currently, as the Chief Financial Officer at Eisai US, his focus is on driving financial strategy and growth. His value proposition lies in his deep industry knowledge, technical expertise, and proven leadership capabilities, making him a vital asset to his organization and the industry at large.
